NO20004844D0 - Fettsyre analoger for behandling av proliferative hudsykdommer - Google Patents

Fettsyre analoger for behandling av proliferative hudsykdommer

Info

Publication number
NO20004844D0
NO20004844D0 NO20004844A NO20004844A NO20004844D0 NO 20004844 D0 NO20004844 D0 NO 20004844D0 NO 20004844 A NO20004844 A NO 20004844A NO 20004844 A NO20004844 A NO 20004844A NO 20004844 D0 NO20004844 D0 NO 20004844D0
Authority
NO
Norway
Prior art keywords
sub
carbon
omega
alkyl
fatty acid
Prior art date
Application number
NO20004844A
Other languages
English (en)
Other versions
NO20004844L (no
Inventor
Rolf Berge
Karsten Kristiansen
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to NO20004844A priority Critical patent/NO20004844L/no
Publication of NO20004844D0 publication Critical patent/NO20004844D0/no
Priority to CN01816441A priority patent/CN100579521C/zh
Priority to RU2003107685/15A priority patent/RU2276602C2/ru
Priority to KR1020037004396A priority patent/KR100905336B1/ko
Priority to EP01975050A priority patent/EP1324756B1/en
Priority to AT01975050T priority patent/ATE418974T1/de
Priority to CA002421729A priority patent/CA2421729A1/en
Priority to AU9441901A priority patent/AU9441901A/xx
Priority to AU2001294419A priority patent/AU2001294419B2/en
Priority to MXPA03002629A priority patent/MXPA03002629A/es
Priority to JP2002530048A priority patent/JP2004509917A/ja
Priority to ES01975050T priority patent/ES2317938T3/es
Priority to NZ524599A priority patent/NZ524599A/en
Priority to US10/363,963 priority patent/US7230029B2/en
Priority to PCT/NO2001/000393 priority patent/WO2002026218A2/en
Priority to DE60137243T priority patent/DE60137243D1/de
Priority to BR0114137-6A priority patent/BR0114137A/pt
Publication of NO20004844L publication Critical patent/NO20004844L/no
Priority to NO20031080A priority patent/NO324555B1/no
Priority to HK04103419.3A priority patent/HK1060692A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20004844A 2000-09-27 2000-09-27 Fettsyre analoger for behandling av proliferative hudsykdommer NO20004844L (no)

Priority Applications (19)

Application Number Priority Date Filing Date Title
NO20004844A NO20004844L (no) 2000-09-27 2000-09-27 Fettsyre analoger for behandling av proliferative hudsykdommer
BR0114137-6A BR0114137A (pt) 2000-09-27 2001-09-27 Análogos de ácido graxo para o tratamento de distúrbios proliferativos da pele
AU2001294419A AU2001294419B2 (en) 2000-09-27 2001-09-27 Fatty acid analogues for the treatment of proliferative skin disorders
JP2002530048A JP2004509917A (ja) 2000-09-27 2001-09-27 増殖性皮膚疾患の治療のための脂肪酸類似体
KR1020037004396A KR100905336B1 (ko) 2000-09-27 2001-09-27 증식성 피부 장애를 치료하기 위한 지방산 유사체
EP01975050A EP1324756B1 (en) 2000-09-27 2001-09-27 Fatty acid analogues for the treatment of proliferative skin disorders
AT01975050T ATE418974T1 (de) 2000-09-27 2001-09-27 Fettsäure-analogen zur behandlung proliferierender hautstörungen
CA002421729A CA2421729A1 (en) 2000-09-27 2001-09-27 Fatty acid analogues for the treatment of proliferative skin disorders
AU9441901A AU9441901A (en) 2000-09-27 2001-09-27 Fatty acid analogues for the treatment of proliferative skin disorders
CN01816441A CN100579521C (zh) 2000-09-27 2001-09-27 用于治疗增生性皮肤病的脂肪酸类似物
MXPA03002629A MXPA03002629A (es) 2000-09-27 2001-09-27 Analogos de acido graso para el tratamiento de enfermedades proliferativas de la piel.
RU2003107685/15A RU2276602C2 (ru) 2000-09-27 2001-09-27 Аналоги жирных кислот для лечения пролиферативных кожных расстройств
ES01975050T ES2317938T3 (es) 2000-09-27 2001-09-27 Uso de analogos de acidos grasos para el tratamiento y/o prevencion de enfermedades proliferativas de la piel.
NZ524599A NZ524599A (en) 2000-09-27 2001-09-27 Fatty acid analogues for the treatment of proliferative skin disorders related to keratinocyte differentiation and proliferation
US10/363,963 US7230029B2 (en) 2000-09-27 2001-09-27 Fatty acid analogues for the treatment of proliferative skin disorders
PCT/NO2001/000393 WO2002026218A2 (en) 2000-09-27 2001-09-27 Fatty acid analogues for the treatment of proliferative skin disorders
DE60137243T DE60137243D1 (de) 2000-09-27 2001-09-27 Fettsäure-analogen zur behandlung proliferierender hautstörungen
NO20031080A NO324555B1 (no) 2000-09-27 2003-03-10 Anvendelse av fettsyreanaloger for a hindre og/eller behandle proliferative hudsykdommer.
HK04103419.3A HK1060692A1 (en) 2000-09-27 2004-05-14 Fatty acid analogues for the treatment of proliferative skin disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20004844A NO20004844L (no) 2000-09-27 2000-09-27 Fettsyre analoger for behandling av proliferative hudsykdommer

Publications (2)

Publication Number Publication Date
NO20004844D0 true NO20004844D0 (no) 2000-09-27
NO20004844L NO20004844L (no) 2002-05-10

Family

ID=19911618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004844A NO20004844L (no) 2000-09-27 2000-09-27 Fettsyre analoger for behandling av proliferative hudsykdommer

Country Status (17)

Country Link
US (1) US7230029B2 (no)
EP (1) EP1324756B1 (no)
JP (1) JP2004509917A (no)
KR (1) KR100905336B1 (no)
CN (1) CN100579521C (no)
AT (1) ATE418974T1 (no)
AU (2) AU2001294419B2 (no)
BR (1) BR0114137A (no)
CA (1) CA2421729A1 (no)
DE (1) DE60137243D1 (no)
ES (1) ES2317938T3 (no)
HK (1) HK1060692A1 (no)
MX (1) MXPA03002629A (no)
NO (1) NO20004844L (no)
NZ (1) NZ524599A (no)
RU (1) RU2276602C2 (no)
WO (1) WO2002026218A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
CN100351259C (zh) 2002-06-20 2007-11-28 Icvec有限公司 含硫的磷脂衍生物
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
MX2007000813A (es) * 2004-07-19 2007-06-05 Thia Medica As Composicion que comprende aceites de pescado y/o de planta y compuestos que comprenden entidades de acido graso no oxidable.
US20100104546A1 (en) * 2007-02-05 2010-04-29 Children, Youth And Women's Health Service Modulators of antigen-dependent t cell proliferation
US8602833B2 (en) 2009-08-06 2013-12-10 May Patents Ltd. Puzzle with conductive path
US9019718B2 (en) 2011-08-26 2015-04-28 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US11330714B2 (en) 2011-08-26 2022-05-10 Sphero, Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US9597607B2 (en) 2011-08-26 2017-03-21 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
USD732475S1 (en) 2012-11-19 2015-06-23 Littlebits Electronics Inc. Connector for modular electronic building system
CA2904827C (en) 2013-03-11 2020-10-27 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
KR102471845B1 (ko) 2016-10-04 2022-11-28 마리 케이 인코포레이티드 튼살 치료를 위한 방법 및 조성물
WO2020053833A1 (en) * 2018-09-14 2020-03-19 Université de Lausanne Methods for modulating regulatory t cells and inhibiting tumor growth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
DE19516705C2 (de) 1995-05-06 1997-10-02 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Substanzen
FR2792312B1 (fr) * 1999-04-15 2001-06-08 Oreal Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger

Also Published As

Publication number Publication date
ES2317938T3 (es) 2009-05-01
KR20030036843A (ko) 2003-05-09
NO20004844L (no) 2002-05-10
ATE418974T1 (de) 2009-01-15
HK1060692A1 (en) 2004-08-20
DE60137243D1 (de) 2009-02-12
CN100579521C (zh) 2010-01-13
MXPA03002629A (es) 2004-05-24
AU9441901A (en) 2002-04-08
AU2001294419B2 (en) 2005-12-01
WO2002026218A3 (en) 2002-06-13
CA2421729A1 (en) 2002-04-04
EP1324756B1 (en) 2008-12-31
RU2276602C2 (ru) 2006-05-20
BR0114137A (pt) 2003-08-12
US20040019108A1 (en) 2004-01-29
JP2004509917A (ja) 2004-04-02
WO2002026218A2 (en) 2002-04-04
KR100905336B1 (ko) 2009-07-01
US7230029B2 (en) 2007-06-12
CN1466453A (zh) 2004-01-07
NZ524599A (en) 2004-11-26
EP1324756A2 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
NO20004844L (no) Fettsyre analoger for behandling av proliferative hudsykdommer
BR9910297A (pt) Novos análogos graxos para o tratamento de diabetes
BR0112399A (pt) Análogos de ácido graxo para o tratamento de câncer
HK1066801A1 (en) Omega-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
BR0108950A (pt) Novos análogos de ácido graxo
CA2458318A1 (en) Wortmannin analogs and methods of using same
RU2002116703A (ru) Аналоги витамина d
NO20014240L (no) C16-umettede FP-selektive prostaglandinanaloger
RU2003107685A (ru) Аналоги жирных кислот для лечения пролиферативных кожных расстройств
ATE416174T1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
AP1777A (en) Use of topical compositions for the control of microbial diseases of the nail.
JPS6485907A (en) Skin-beautifying cosmetic
MXPA05006296A (es) Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application